What to Expect at Your First Ketamine Infusion: A Complete Patient Guide (2026)

By Eric Bryant, Mental Health Worker | Updated April 2026

Ketamine infusion therapy is one of the fastest-acting antidepressant treatments ever studied — and the experience itself is unlike any other medical treatment. A single IV infusion produces dissociative, dream-like states that can feel profoundly healing for some patients and disorienting for others. Real-world data from over 9,000 patients across 178 U.S. practices shows a 53.6% clinical response rate and 28.9% remission rate for treatment-resistant depression (McInnes et al., Journal of Affective Disorders, 2022), with effects beginning as early as the first session.

This guide covers every step — from screening through maintenance — so you know exactly what to expect before, during, and after your first infusion.

Before anything else: the screening process

Before you receive your first infusion, the clinic will conduct a thorough medical and psychiatric evaluation. This is the most important safety step in the entire process — not a formality.

The psychiatric evaluation confirms a qualifying diagnosis, typically treatment-resistant depression, PTSD, or severe anxiety. Most clinics require documented failure of at least two adequate antidepressant trials, consistent with the APA Consensus Statement (Sanacora et al., JAMA Psychiatry, 2017). The clinic will measure your baseline symptoms using validated instruments like the PHQ-9 or MADRS, which later serve as benchmarks for tracking improvement.

The medical history review covers cardiovascular health, liver function, history of psychosis or mania, substance use, and pregnancy status. Labs typically include liver function tests and creatinine (the liver is ketamine's primary metabolic organ), a urine toxicology screen, and baseline blood pressure. An EKG may be recommended if you have cardiovascular risk factors. The entire screening process usually takes one to two weeks.

Who should not receive ketamine therapy

Based on the ASRA/AAPM/ASA Consensus Guidelines (2018) and APA Consensus Statement (2017), the following conditions may make ketamine therapy inappropriate or require significant caution:

Uncontrolled hypertension (≥180/110 mmHg)
Active psychosis or schizophrenia
Pregnancy
Severe or decompensated cardiovascular disease
Elevated intracranial or intraocular pressure (including untreated glaucoma)
Severe liver dysfunction
Known allergy to ketamine
Active substance use disorder or ketamine use disorder

If any of these apply to you, discuss them openly with your provider — don't self-exclude without a conversation.

Medications to discuss with your provider before treatment

How your current medications interact with ketamine is one of the most important — and most poorly understood — aspects of treatment. Here's what the peer-reviewed evidence actually shows.

Benzodiazepines (Xanax, Ativan, Klonopin, Valium): These reduce ketamine's antidepressant effect. A 2020 study found that higher benzodiazepine doses were associated with significantly worse outcomes at day 3 and day 7 (Andrashko et al., Frontiers in Psychiatry). A 2021 systematic review concluded that benzodiazepines repeatedly reduce the duration of ketamine's antidepressant effect (Hasler et al., International Journal of Neuropsychopharmacology). Most clinics advise holding benzodiazepines on infusion day — but never stop them abruptly without your prescriber's guidance.

Naltrexone: The evidence here is striking. A double-blind crossover trial at Stanford found that naltrexone pretreatment essentially eliminated ketamine's antidepressant effect — the study was stopped early because the combination was ineffective (Williams et al., American Journal of Psychiatry, 2018). A 2025 study in Nature Medicine also found that naltrexone attenuated ketamine's antidepressant effects (Jelen et al.). Many clinics ask patients to stop oral naltrexone in advance of infusion; exact timing should be individualized with your prescriber. If you're on depot naltrexone (Vivitrol), which lasts approximately 30 days, discuss scheduling carefully with your provider.

Lamotrigine: The evidence is mixed, and most clinics do not require discontinuation. A 2025 Yale study of 347 patients found no clinical evidence of an interaction between lamotrigine and ketamine/esketamine treatment (Psychopharmacology, 2025).

SSRIs and SNRIs: Safe to continue. Ketamine and SSRIs act on different neurotransmitter systems (glutamate versus serotonin). Expert consensus holds that ketamine can be safely added to ongoing antidepressant regimens.

MAOIs: Labeled as contraindicated based on theoretical risks of hypertensive crisis, but a systematic review found no confirmed reports of serotonin syndrome or hypertensive crisis from the combination (Hasler et al., 2021). This should only be attempted by experienced providers with cardiovascular monitoring.

Opioids: Not an automatic disqualifier, but they require enhanced monitoring due to the risk of respiratory depression.

Cannabis: No controlled studies have established a clinically significant THC-ketamine interaction for depression. Most clinics recommend abstaining for 24–72 hours before infusion as a precaution.

The 24 hours before your infusion

Preparation makes a real difference in both safety and experience quality.

Fasting: No solid food for 4–6 hours before your infusion (some clinics require up to 8 hours). Clear liquids — water, apple juice, black coffee — are allowed up to 2 hours before. This reduces nausea risk during the dissociative state.

The night before: Get a full night of sleep if possible. Being well-rested reduces anxiety and helps your body respond to treatment. If anxiety about the appointment keeps you up, that's normal and worth mentioning to your provider.

What to bring: An eye mask, headphones with a calming music playlist, a light blanket, and comfortable loose-fitting clothing with easy arm access for the IV (short sleeves or a button-up work well). Some clinics provide these items, but bringing your own ensures comfort.

Medications: Hold benzodiazepines and stimulants (ADHD medications) on treatment day. Avoid alcohol and cannabis for at least 24 hours. Continue your regular SSRI or SNRI with small sips of water.

Transportation: Arrange a driver in advance. You cannot drive for at least 12–24 hours after your infusion. This is universally required by every clinic — no exceptions.

What happens during your infusion, step by step

A typical IV ketamine appointment lasts approximately two hours total: pre-assessment, the 40-minute infusion, and post-infusion observation.

Settling in. You'll be brought to a private treatment room with a comfortable reclining chair or bed, dim lighting, and often a therapeutic music playlist. The atmosphere is calm and unhurried — nothing like a hospital setting.

The IV. A nurse places a small IV catheter in your hand or arm. Monitoring equipment is attached: a blood pressure cuff (readings every 5–15 minutes), pulse oximetry for oxygen saturation, and heart rate monitoring.

The infusion begins. The standard dose is 0.5 mg/kg delivered over 40 minutes — the protocol established by the landmark Zarate et al. study (2006) and confirmed by the APA Consensus Statement. For a 154 lb (70 kg) person, that's approximately 35 mg. Some clinics start lower for anxious patients or increase the dose in later sessions for non-responders.

The critical advantage of IV administration is real-time control: the infusion can be slowed, paused, or stopped immediately based on your response, with effects fading within minutes. No other administration route offers this level of precision.

You put on your eye mask and headphones. Within 5–10 minutes, you begin to feel the effects. A qualified licensed clinician supervises throughout, according to the clinic's protocols and state requirements.

If anything goes wrong: If blood pressure rises too high, the infusion is slowed or medication is given. If nausea occurs, ondansetron (Zofran) is administered through your IV. If the dissociation becomes too intense, reducing the infusion rate causes effects to begin fading within minutes.

What the experience actually feels like

Clinical language fails to capture what ketamine actually feels like. Here's what patients report — the full range, including difficult experiences.

The onset

The experience begins within minutes. Susan Gayhart, a long-term ketamine patient, described it: "I remember saying to my husband who was in the room with me, 'I don't know where my body is.' I couldn't see my entire body."

The most common physical sensations patients describe are floating, weightlessness, "melting into the chair," and warmth. Tingling in lips and fingertips is frequently reported.

Visual and sensory effects

Visual experiences range from nothing at all to vivid, immersive landscapes. Patients consistently describe fractals, geometric patterns, kaleidoscope-like imagery, and three-dimensional colors. Time distortion is universal — a 40-minute infusion can feel like 10 minutes or two hours.

Sean, a patient who shared his experience on the Osmind blog, described the cognitive quality: "You're so willing to go deep and you're listening and trying to relax even more. And then I start to float, and my brain disassociates from my body." He also offered reassurance about controllability: "If you open your eyes, that will take you right out of the psychedelic aspect instantly and you feel just kind of buzzed. So, I tell people if you're afraid, don't be."

Not every experience is pleasant — and that's important to know

Some patients experience euphoria and profound peace. Others experience fear or sadness. The "ketamine crying" phenomenon is well-documented: patients cry during infusions, often processing years of suppressed emotion. Gayhart described it: "I cried during two of the treatments... Dr. Levine reassured me that crying is natural when you have years of stored unexamined emotions."

On the other end of the spectrum, some patients find the experience genuinely frightening. One user on Drugs.com described it as "the most terrifyingly awful experience I have ever had" — feeling as if they were dying during the dissociative state. This is not the norm, but it's real, and honest providers will discuss this possibility before treatment.

Clinical observations suggest that sessions 2–4 of a 6-session series typically bring up the most intense emotional processing. Each session is different, even for the same person.

Recovery: the hours and days after

Dissociative effects begin fading within 10–15 minutes of infusion completion. Most patients feel grounded within 15–30 minutes, though some grogginess may persist for 1–2 hours. You'll stay at the clinic for an additional 20–45 minutes while staff monitor your vitals and offer light food and water.

The rest of the day: Plan to do nothing. Fatigue on infusion day is nearly universal. Don't drive, don't make important decisions, and avoid alcohol for at least 24 hours. Most patients feel significantly more clear-headed by the next morning.

The emotional aftermath: Patients commonly report feeling "emotionally tender," reflective, or slightly raw for 24–72 hours. This is a normal part of the process. Some patients notice mood improvement within hours of their first infusion; for others, benefits build gradually across the series.

The neuroplasticity window

The 24–72 hours after infusion is when clinicians recommend leveraging enhanced neuroplasticity — the brain's heightened ability to form new connections. The underlying neurobiology is well-supported: ketamine rapidly increases Brain-Derived Neurotrophic Factor (BDNF), promoting new synaptic growth.

Important caveat: The "72-hour neuroplasticity window" as a precise timeframe is a practitioner-derived concept based on animal studies and emerging human neuroimaging data. The biology is real, but the exact duration hasn't been defined by a single controlled human trial. Think of it as an approximation, not a hard deadline.

Clinics recommend during this period: scheduling psychotherapy within 1–3 days, journaling (start within an hour of your session), mindfulness meditation, gentle exercise, adequate sleep, and avoiding alcohol, cannabis, and emotionally charged situations.

How different administration routes compare

Ketamine therapy isn't one-size-fits-all. The route of administration fundamentally changes the experience, cost, and level of medical supervision.

	IV Infusion	IM Injection	Sublingual	Spravato (Nasal)	At-Home Oral
Onset	~30 seconds	~5 minutes	15–30 min	15–20 min	20–60 min
Duration	40–60 min	30 min–2 hrs	45 min–several hrs	1–2 hours	1–3 hours
Dissociation	Highest	High	Lower	Moderate	Low–moderate
Setting	Clinic only	Clinic	Clinic or home	REMS-certified clinic	Home (telehealth)
Real-time dose control	Yes	No	No	No	No
Cost/session	$400–$800	$275–$400	$54–$200	$590–$1,200+	$129–$200/mo
6-session cost	$2,400–$6,400	$1,600–$2,400	$800–$1,200	$4,700–$10,000+	$250–$400 total
Insurance	Rarely	Rarely	No	Yes (most plans)	No

IV infusion remains the gold standard in research — its 100% bioavailability and real-time titration make it the most precise and controllable route. Spravato (esketamine nasal spray) is the only FDA-approved ketamine product for psychiatric use and is increasingly covered by insurance.

For a deeper comparison of Spravato versus IV ketamine — including insurance coverage, effectiveness data, and side effects — see our Spravato vs. Ketamine comparison guide.

For a full breakdown of at-home ketamine providers — pricing, safety records, and clinical oversight levels — see our At-Home Ketamine Providers Compared guide.

The treatment protocol: how many sessions and when you'll notice improvement

The standard induction

The standard protocol is 6 IV infusions over 2–3 weeks — either 3 times per week for 2 weeks, or twice weekly for 3 weeks. This protocol is supported by multiple clinical studies and used by major academic centers including Northwestern Medicine. Some clinics use 4 sessions as a minimum induction; others extend to 8.

Dose escalation across sessions is common. Providers may increase from the starting 0.5 mg/kg by 0.1 mg/kg increments for non-responders, with a typical ceiling of 0.75 mg/kg.

When patients notice improvement

Some patients experience dramatic relief after the first infusion — within hours. However, other studies show a more gradual trajectory. The clinical consensus is that some change is typically noticed by sessions 2–3, with full benefit requiring the complete 6-session induction.

An important note on response rates: Many clinic websites cite a "70% response rate." The largest real-world dataset — McInnes et al., tracking 9,016 patients across 178 practices — found a 53.6% response rate and 28.9% remission rate. These real-world figures are more representative than smaller early trials and are important for setting realistic expectations.

Maintenance

After induction, patients transition to maintenance infusions at decreasing frequency. A typical progression: weekly sessions in month 2, every 2–4 weeks in months 3–6, then monthly or as-needed long-term. After a full induction course, approximately 80% of responders maintain their response at 4 weeks and 60% at 8 weeks even without maintenance (McInnes et al., Kaplan-Meier analysis).

Ketamine combined with cognitive behavioral therapy has been shown to extend the median time to relapse (Wilkinson et al., Psychological Medicine).

Side effects: what the data actually shows

During infusion — common and transient

A comprehensive analysis of 188 participants across five NIH studies (Short et al., Journal of Affective Disorders, 2018) found the most common transient effects include:

Dissociation: The majority of patients experience this (it is the intended pharmacological effect)
Nausea: Roughly a third of patients
Dizziness and blurred vision: Common, reported by a significant minority
Blood pressure increase: Transient elevations, typically modest
Anxiety or fear: A smaller percentage, more common during initial sessions

Most side effects peak within 1 hour and resolve completely by 2 hours post-infusion. Importantly, dissociative symptoms tend to decrease with repeated sessions (Singh et al., 2016).

After infusion — brief and manageable

Fatigue lasts 2–4 hours on infusion day. Headache occurs in over 10% of patients but usually resolves within 24 hours. Transient cognitive effects (mild memory or recall difficulty) dissipate within 2 hours. Studies tracking cognitive function at 7 days post-infusion found no measurable decline.

Rare but serious risks — with context

Bladder issues: The most frequently cited long-term concern, but context matters enormously. Recreational users consuming grams daily develop interstitial cystitis at rates of 20–30%. At therapeutic doses, the risk is vanishingly small: only one confirmed case of cystitis attributed to therapeutic ketamine for depression exists in the literature as of 2026. The SUSTAIN-3 study tracked esketamine patients for up to 6.5 years (3,777 patient-years) and found zero cases of interstitial or ulcerative cystitis (Zaki et al., International Journal of Neuropsychopharmacology, 2025).

Psychological dependence: Not demonstrated at therapeutic doses in clinical settings. SUSTAIN-3 found no evidence of abuse, misuse, or withdrawal over 6.5 years.

Blood pressure spikes: Typically transient and clinically significant in fewer than 10% of patients. Clinics monitor throughout and have medications on hand.

Compared to traditional antidepressants

SSRIs cause chronic daily side effects — sexual dysfunction in 30–70% of patients, weight gain, and emotional blunting — that persist for as long as you take them. Ketamine's side effects are acute and transient, lasting hours rather than months. It causes no sexual dysfunction and no weight gain. The trade-off is that ketamine requires clinic visits and carries acute hemodynamic risks, while SSRIs are taken daily at home.

How much ketamine therapy costs — and how to pay for it

IV ketamine runs $400–$800 per session nationally, with a full 6-session induction costing $2,400–$6,400 out of pocket. Geographic variation is substantial: major metros like New York, Los Angeles, and San Francisco charge $600–$1,400+ per session, while smaller markets can offer the same protocol for as low as $350.

For clinic-specific pricing in your area — based on data from 600+ clinics tracked by PsychedelicBeacon — see our complete ketamine cost guide.

Why insurance usually doesn't cover IV ketamine

IV and IM ketamine are almost never covered because racemic ketamine is FDA-approved only as an anesthetic — all psychiatric uses are off-label. Insurers classify it as "experimental." Limited exceptions include some VA referrals and certain Kaiser Permanente, Aetna, and BCBS plans. Many clinics provide superbills for out-of-network PPO reimbursement.

Spravato is different

Spravato has FDA approval for treatment-resistant depression, which means most commercial insurers and Medicare Part B cover it with prior authorization. The Janssen CarePath Savings Program can reduce commercially insured copays to as low as $10 per session.

Other ways to pay

HSA and FSA funds can be used for ketamine therapy as a prescribed medical expense (IRS Publication 502). Medical financing through CareCredit is widely accepted at ketamine clinics. Several nonprofits also offer financial assistance, including the Serenity Foundation and Thank You Life.

For 10 specific pathways to afford treatment, see our How to Pay for Ketamine Therapy guide.

Red flags: how to evaluate a ketamine clinic

What to look for

The ideal provider combines psychiatric expertise with sedation competency. Providers should be ACLS-certified and have specific ketamine training. Membership in the American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3) signals commitment to ethical standards.

Warning signs

No comprehensive screening before treatment (the most dangerous red flag)
No vital sign monitoring during infusions
No qualified provider physically present throughout
Lack of emergency equipment
Pressure to commit to expensive prepaid packages with no refund policy
Promises of "guaranteed cures" or 100% success rates
Use of "proprietary blends" or "secret formulations"

Questions to ask before committing

What are your medical credentials and specific ketamine training?
Will a qualified medical professional be physically present throughout my entire infusion?
What vital signs do you monitor, and how frequently?
What is your protocol for severe side effects?
What dose and infusion rate do you use, and how do you individualize treatment?
How do you measure whether treatment is working (do you use validated rating scales)?
Do you offer integration therapy or coordination with my existing psychiatrist?
What exactly is included in the session price — are there hidden fees?

Pricing red flags

ASKP3 recommends $400–$800 as a reasonable range for IV ketamine. Pricing below $350 should prompt questions about what safety measures may be compromised. Pricing above $1,000 should prompt questions about what additional value is being provided.

Ready to find a provider? Browse our directory of 750+ ketamine clinics with pricing data to compare options in your area.

Frequently Asked Questions

How long does a ketamine infusion appointment take? Approximately 2 hours total: a brief pre-assessment, the 40-minute infusion itself, and 20–45 minutes of post-infusion observation.

Does ketamine therapy hurt? The only physical discomfort is the small IV needle insertion, similar to having blood drawn. The infusion itself is painless.

Can I drive myself home after a ketamine infusion? No. Every clinic requires you to arrange a driver. You cannot drive for at least 12–24 hours after treatment.

How quickly does ketamine work for depression? Some patients notice improvement within hours of their first infusion. Most experience noticeable change by sessions 2–3. Full benefit typically requires completing the 6-session induction course.

Is ketamine therapy safe long-term? The SUSTAIN-3 study tracked esketamine patients for up to 6.5 years and found no new safety concerns, no cognitive decline, no bladder issues, and no evidence of dependence. A 2025 analysis of nearly 60,000 patients confirmed the safety profile.

Will I be unconscious during the infusion? No. Ketamine at therapeutic doses produces a dissociative state — you remain conscious but may feel detached from your body and surroundings. You can open your eyes at any time, which quickly reduces the intensity.

What if I have a bad experience during the infusion? The IV route allows real-time dose adjustment. If the experience becomes too intense, your provider can slow or stop the infusion, and effects begin fading within minutes.

Does insurance cover ketamine therapy? IV ketamine is rarely covered because psychiatric use is off-label. Spravato (esketamine nasal spray) is FDA-approved and covered by most commercial insurance and Medicare with prior authorization. See our How to Pay for Ketamine Therapy guide for all options.

This guide is for informational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a qualified medical provider. If you are experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by calling or texting 988.

Eric Bryant is a mental health worker at a psychiatric hospital and the founder of PsychedelicBeacon.com.